Cargando…

Treatment of peritoneal metastases from colorectal cancer

Peritoneal seedings of a colorectal tumor represent the second most frequent site of metastasis (after the liver). In the era of 5-fluorouracil (5-FU)-only chemotherapy, the prognosis was poor for colorectal cancer with peritoneal metastases. Within the last few years, new chemotherapeutic and targe...

Descripción completa

Detalles Bibliográficos
Autores principales:	März, Loreen, Piso, Pompiliu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650975/ https://www.ncbi.nlm.nih.gov/pubmed/26424828 http://dx.doi.org/10.1093/gastro/gov044

Ejemplares similares

Peritoneal Metastases
por: Yonemura, Yutaka, et al.
Publicado: (2012)

Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details
por: Boerner, Thomas, et al.
Publicado: (2021)

Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Glockzin, Gabriel, et al.
Publicado: (2009)

“En bloc” caudate lobe and inferior vena cava resection following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal and liver metastasis of colorectal cancer
por: Sánchez-Velázquez, Patricia, et al.
Publicado: (2016)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004)

Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis
por: Glockzin, Gabriel, et al.
Publicado: (2014)

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial
por: Glockzin, Gabriel, et al.
Publicado: (2013)

Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts
por: Herold, Zoltan, et al.
Publicado: (2022)

The Characteristics of 206 Long-Term Survivors with Peritoneal Metastases from Colorectal Cancer Treated with Curative Intent Surgery: A Multi-Center Cohort from PSOGI
por: Kamada, Yasuyuki, et al.
Publicado: (2021)

Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
por: Steinhoff, Heinrich, et al.
Publicado: (2023)

Multidisciplinary Treatment for Colorectal Peritoneal Metastases: Review of the Literature
por: Mo, Shaobo, et al.
Publicado: (2016)

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
por: Acs, Miklos, et al.
Publicado: (2022)

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
por: Simkens, Geert A, et al.
Publicado: (2017)

Treatment of patients with peritoneal metastases from gastric cancer
por: Kitayama, Joji, et al.
Publicado: (2018)

Colorectal peritoneal metastases: Optimal management review
por: Sánchez-Hidalgo, Juan Manuel, et al.
Publicado: (2019)

Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference Centers for CRS
por: Acs, Miklos, et al.
Publicado: (2023)

Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges
por: Kranenburg, Onno, et al.
Publicado: (2021)

Colorectal Cancer with Peritoneal Metastases: The Impact of the Results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 Trials on Peritoneal Disease Management
por: Sommariva, Antonio, et al.
Publicado: (2022)

Comparison of Cytoreductive Surgery and Resection of Isolated Peritoneal Metastases in Patients with Peritoneal Metastases from Colorectal Cancer: A Retrospective Study
por: Yoshida, Shinya, et al.
Publicado: (2023)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience
por: Liu, Yang, et al.
Publicado: (2018)

Factors Prognostic for Peritoneal Metastases from Colorectal Cancer Treated with Surgery
por: Chen, Chao, et al.
Publicado: (2020)

Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer
por: Spiegelberg, Julia, et al.
Publicado: (2020)

Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
por: Pauli, Griffin, et al.
Publicado: (2021)

Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer
por: Heuvelings, Danique J. I., et al.
Publicado: (2023)

Gastric Cancer with Peritoneal Metastases: Current Status and Prospects for Treatment
por: Manzanedo, Israel, et al.
Publicado: (2023)

Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases
por: Klaver, Charlotte E. L., et al.
Publicado: (2017)

Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers
por: Blaj, Sebastian, et al.
Publicado: (2023)

Diagnosis and Management of Peritoneal Metastases from Ovarian Cancer
por: Halkia, Evgenia, et al.
Publicado: (2012)

Detection of peritoneal metastases
por: Healy, Jeremiah C.
Publicado: (2015)

Prevention and Treatment of Peritoneal Metastases from Gastric Cancer
por: Sugarbaker, Paul H.
Publicado: (2021)

Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid
por: van't Erve, Iris, et al.
Publicado: (2021)

Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer
por: Kim, Young Jin, et al.
Publicado: (2021)

Treatment Response After Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases of Colorectal Originf
por: Hübner, Martin, et al.
Publicado: (2022)

Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer
por: Verheij, F. S., et al.
Publicado: (2020)

Role of Peritoneal Mesothelial Cells in the Progression of Peritoneal Metastases
por: Li, Junliang, et al.
Publicado: (2022)

The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
por: Sun, Beatrice J., et al.
Publicado: (2023)

Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
por: Cashin, Peter H, et al.
Publicado: (2023)

Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study
por: Mahteme, H, et al.
Publicado: (2004)

The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries
por: Ravn, Sissel, et al.
Publicado: (2020)

DNA and RNA Alterations Associated with Colorectal Peritoneal Metastases: A Systematic Review
por: Heuvelings, Danique J. I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8cqrsmf7528vd87ilqgmp3nsre